News from NYU Langone Health
Q&A: 3-Year Medical School Achieves Competency “Without Compromising On The Quality.” (Healio)
Healio (11/1) An analysis published in Academic Medicine shows NYU Grossman School of Medicine’s accelerated 3-year MD program maintains educational quality comparable to traditional 4-year programs, with Joan F. Cangiarella, MD, the Elaine Langone Professor of Pathology, Department of Pathology, chief, Pathology Service, Tisch Hospital, Senior Associate Dean for Education, Faculty and Academic Affairs, Vice Chair, Clinical Operations and the pathway’s director, saying the program is “an efficient, cost-effective way to prepare medical students for the next stage of training without compromising on the quality.”
The Symptoms Of Colon Cancer That Every Young Woman Should Know About. (Women's Health (AUS))
Women’s Health (AUS) (11/3) Cases of “early-onset colorectal cancer, while still relatively rare, have been rising since the mid-1990s,” but research aren’t sure why, with Lisa Ganjhu, DO, clinical associate professor, Department of Medicine, Division of Gastroenterology and Hepatology, saying, “It could be related to stress, or diet or other behaviours; more research is being done to help us understand the rise.”
Americans Hungry For Weight-Loss Drugs Grapple With Supply And Insurance Hurdles. (Reuters)
Reuters (11/4) The FDA last week “listed all doses of Wegovy as available, though it has yet to come off the shortage list,” which “attracted renewed interest among patients put off by shortages earlier in the year,” with Holly F. Lofton, MD, clinical associate professor, Departments of Surgery, Division of Bariatric Surgery, and Medicine, Division of General Internal Medicine, saying, “We’re getting more people back now who were frustrated because they couldn’t get meds in the spring and stopped because of shortage.”
Health Rounds: No Need To Stop GLP-1 Drugs Before Surgery For Most Patients. (Reuters)
Reuters (11/1) Medical societies have reversed guidelines, now suggesting it “might be best to follow a 24-hour clear liquid diet prior to GI endoscopy without discontinuing GLP-1 therapy,” according to findings “presented by Violeta B. Popov, MD, PhD, associate professor, Department of Medicine, Division of Gastroenterology and Hepatology, on Wednesday at the American College of Gastroenterology meeting in Philadelphia.”
What Suburban Parents Need To Know About Rise Of ‘Walking Pneumonia’ In Children. (Chicago Daily Herald)
The Chicago Daily Herald (11/3) Adam J. Ratner, MD, professor, Departments of Pediatrics, and Microbiology, Hassenfeld Children’s Hospital, said, “Mycoplasma is something we see every year, but we mostly see it in that older age range of children.”
Experts Explain How To Get Rid Of Headaches. (WGGB-TV Springfield (MA))
WGGB-TV Springfield, MA (11/1) Myrna I. Cardiel, MD, clinical professor, Departent of Neurology discussed the best way to address headaches, saying, “Time is of the essence. You have to take medication right away. And one of the things that we discuss with our patients here in the office is we talk about treating immediately.”
Balancing Benefits And Risks Of Amivantamab. (American Journal of Managed Care)
The American Journal of Managed Care (11/2) Joshua K. Sabari, MD, assistant professor, Department of Medicine, Division of Hematology and Medical Oncology, Perlmutter Cancer Center discussed the toxicities accompanying amivantamab and “its intravenous administration, in particular, the skin-related reactions and the risk of venous thromboembolism.”
Lexicon Loses FDA Adcomm Vote On Insulin Adjunct For Patients With Type 1 Diabetes. (BioSpace)
BioSpace (11/1) “The FDA’s Endocrinologic and Metabolic Drugs Advisory Committee on Thursday voted against Lexicon Pharmaceuticals’ investigational type 1 diabetes therapy sotagliflozin,” as “the external experts wanted to see more data in patients with eGFR values from 60 to less than 90, indicating relatively mild kidney damage or earlier-stage disease, for whom sotagliflozin appears to be more beneficial;” Connie Newman, MD, adjunct professor, Department of Medicine, Division of Endocrinology, Diabetes & Metabolism, said during the meeting, “I felt that there was an uncertainty about the benefit-risk.”
FDA Panel Rejects SGLT1/2 Inhibitor For Type 1 Diabetes. (MedPage Today)
MedPage Today (11/1) An FDA advisory panel voted 11-3 against recommending sotagliflozin as an adjunct treatment for type 1 diabetes patients with mild-to-moderate chronic kidney disease, with Connie Newman, MD, adjunct professor, Department of Medicine, Division of Endocrinology, Diabetes & Metabolism, saying she is “struggling” with balancing the data “against the real risk of DKA.”
GLP-1 RAs Reduce Early-Onset CRC Risk In Patients With Type 2 Diabetes. (Pulmonary Health Hub)
Pulmonary Health Hub (10/31) A study presented at the American College of Gastroenterology meeting highlights that GLP-1 receptor agonists (RAs) may reduce early-onset colorectal cancer (EO-CRC) risk in patients under 50 with type 2 diabetes (T2D), with Aasma Shaukat, MD, MPH, the Robert M. and Mary H. Glickman Professor of Medicine, Department of Medicine, Division of Gastroenterology and Hepatology, professor, Department of Population Health, “who was not affiliated with the research,” saying, “We do need more studies such as this to generate hypotheses that can be studied prospectively,”
Taking On Acquired Resistance In EGFR-Mutant NSCLC. (MedPage Today)
MedPage Today (11/1) Vamsidhar Velcheti, MD, professor, Department of Medicine, Division of Hematology and Medical Oncology, Perlmutter Cancer Center, discussed resistance to third-generation EGFR TKIs like osimertinib being very heterogeneic.
Research Evaluates Sexual QOL In Female Partners Of Patients With Prostate Cancer. (Urology Times)
Urology Times (11/2) Stacy Loeb, MD, professor, Departments of Urology, and Population Health, Perlmutter Cancer Center, “gives an overview of the study ‘Impact of Prostate Cancer on Sexual Quality of Life for Female Partners of Patients,’ which she presented at the 2024 Sexual Medicine Society of North America Fall Scientific Meeting in Scottsdale, Arizona.”
What Happens To The Vulva And Vagina After Birth. (PopSugar)
PopSugar (11/1) Physical changes occur to the vulva and vagina after childbirth, which can include swelling, labia darkening, and vaginal dryness, in addition to the vulva becoming “hypervascularized,” which means “there’s a lot of blood flow to it,” according to Taraneh Shirazian, MD, associate professor, Department of Obstetrics & Gynecology, director, Center for Fibroid Care,.
Anyone Over 50 Should Be Getting These 5 Vaccines, Doctors Say. (Fox News)
Fox News (10/31) Marc K. Siegel, MD, clinical professor, Department of Medicine, Division of General Internal Medicine and Clinical Innovation discussed the importance of vaccinations among school-age children and whether people should get flu and COVID shots at the same time.
News from NYU Langone Hospital—Long Island
James Van Der Beek Says There’s ‘No Playbook’ On How To Share News About Colorectal Cancer Diagnosis. (Insider)
Insider (11/3) Although “experts are unsure about the exact cause behind the rise in cases, Michael Shusterman, MD, assistant professor, Department of Medicine Division of Hematology and Medical Oncology, Perlmutter Cancer Center, NYU Langone Hospital–Island, told BI that making certain lifestyle changes can reduce the risk of developing colorectal cancer.”
